Isis Biopolymer is awarded the 2010 Rising Star for Innovation From SBANE

PROVIDENCE, R.I., May 19 /PRNewswire/ -- Isis Biopolymer has been awarded the 2010 Rising Star Award by SBANE (Smaller Business Association of New England). The Rising Star is a coveted annual award that honors innovative products and services offered by early-stage companies in New England.

SBANE recognizes the intrinsic value that innovation possesses in driving the New England economy. To that end, SBANE utilizes its highly competitive innovation awards program to showcase technology-driven enterprises that are potentially "game changers" in their markets. Innovation is at the heart of economic prosperity and SBANE continues to recognize those companies that have transformed their innovative ideas into a product or service that delivers proven value to customers.

This year, SBANE received 182 nominations from innovative corporations who have unique growth characteristics and traction in their respective markets. Previous winners include iRobot and Cubist Pharmaceuticals.

The IsisIQ™ Patch is a fully programmable, multi-day, multi-drug, transdermal drug delivery patch.  The IsisIQ™ patch is a compact, non-invasive, wireless, patch which uses a patented design offering advances in microprocessors, thin-film batteries, and polymer thick film.

"We are honored to have been recognized by SBANE for our innovation and game changing technology for transdermal delivery of prescription drugs and over the counter products," says Shawna Gvazdauskas, Chief Commercial Officer, Isis Biopolymer. "We are also proud of the fact that we develop and manufacture our patches in Providence, RI."

About Isis Biopolymer, Inc.

Isis Biopolymer is an innovative medical device company focused on the development and commercialization of transdermal drug delivery and biosensors as well as integrated wireless communication platforms for personalized medicine.

Isis Biopolymer's products are currently undergoing clinical trials for use in the following treatments and chronic conditions: smoking cessation, diabetes, cardiovascular disease, attention deficit hyperactivity disorder and pain management.

SOURCE Isis Biopolymer

Back to top

RELATED LINKS
http://www.isisbiopolymer.com